Skip to main content

Viatris Inc Yupelri ® revenue

  • VTRS · Nasdaq
  • Pharmaceuticals
  • S&P 500
$20.82+0.73%Close 13 Nov 2026

Yupelri ® revenue at Viatris Inc came to $71.5M for the quarter to 30 Sep 2026, up 0.1% from a year earlier.

As Viatris Inc reported it in its earnings release and quarterly or annual report, compiled and checked by AapWire. Latest figure filed 5 Nov 2026.

By quarter

$60.5MDec 2023$55.2MMar 2024$54.5MJun 2024$62.2MSep 2024$66.6MDec 2024$58.3MMar 2025$66.6MJun 2025$71.4MSep 2025$70.6MDec 2025$62.5MMar 2026$70.7MJun 2026$71.5MSep 2026
Viatris Inc Yupelri ® revenue, every reported period
Period endingYupelri ® revenueChange on a yearFiled
30 Sep 2026$71.5Mup 0.1%5 Nov 2026
30 Jun 2026$70.7Mup 6.2%6 Aug 2026
31 Mar 2026$62.5Mup 7.2%7 May 2026
31 Dec 2025$70.6Mup 6.0%26 Feb 2026
30 Sep 2025$71.4Mup 14.8%6 Nov 2025
30 Jun 2025$66.6Mup 22.2%7 Aug 2025
31 Mar 2025$58.3Mup 5.6%8 May 2025
31 Dec 2024$66.6Mup 10.1%27 Feb 2025
30 Sep 2024$62.2Mup 6.7%7 Nov 2024
30 Jun 2024$54.5Mdown 0.9%8 Aug 2024
31 Mar 2024$55.2Mup 17.4%9 May 2024
31 Dec 2023$60.5Mup 8.0%28 Feb 2024
30 Sep 2023$58.3Mup 9.2%8 Nov 2023
30 Jun 2023$55.0Mup 12.0%7 Aug 2023
31 Mar 2023$47.0Mup 7.6%8 May 2023
31 Dec 2022$56.0Mup 12.2%27 Feb 2023
30 Sep 2022$53.4Mup 35.5%7 Nov 2022
30 Jun 2022$49.1Mup 17.5%8 Aug 2022
31 Mar 2022$43.7Mup 18.4%9 May 2022
31 Dec 2021$49.9M—28 Feb 2022
30 Sep 2021$39.4M—8 Nov 2021
30 Jun 2021$41.8M—9 Aug 2021
31 Mar 2021$36.9M—10 May 2021

Definition

Revenue from this part of the business, as the company names and reports it in its results. Each figure is read from the table or sentence the company printed and kept with its scale and decimals; see data and methodology.

Other operating KPIs of Viatris Inc: Brands revenue · Generics revenue · Lipitor revenue · Norvasc revenue · EpiPen® Auto-Injectors revenue · Lyrica ® revenue · Creon ® revenue · Viagra ® revenue · Influvac ® revenue · Zoloft ® revenue · Celebrex ® revenue · Effexor ® revenue · Xalabrands revenue · Xanax ® revenue · Amitiza ® revenue · Dymista ® revenue · Developed Markets Segment revenue · Greater China revenue · Emerging Markets Segment revenue · Japan, Australia and New Zealand Segment revenue · financial statements

Every KPI and segment of VTRS, in the terminal.

Ten years of operating figures, segments, guidance against results, charts and alerts on each new release.